193 results
Page 3 of 10
6-K
a2dx1gzzgkua8
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
EX-99.1
v58ka21h8tjaaw71v
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
3hcwkj 428s
8 Dec 22
Current report (foreign)
6:46am
6-K
EX-99.1
3n9u0 qke1dn
30 Nov 22
Current report (foreign)
6:28am
6-K
iufrb7
4 Nov 22
Current report (foreign)
6:01am
6-K
6166 1m4k7awwlv
27 Oct 22
Current report (foreign)
6:01am
6-K
4fj7pnp53iqy9 ov
14 Oct 22
Current report (foreign)
7:36am
6-K
y0zidrilzrpxjcbqs0o
4 Oct 22
Current report (foreign)
6:06am
6-K
EX-99.1
ipfi6krh4ag 33m28
23 Aug 22
Current report (foreign)
6:13am
6-K
7hw4dy05d4t4gocxg
4 Aug 22
Current report (foreign)
6:07am
6-K
1h9soc9c c7
28 Jul 22
Current report (foreign)
6:09am
6-K
zoya96zg765jii
11 Jul 22
Current report (foreign)
6:05am
6-K
9td8208flti69q183ehj
29 Jun 22
Current report (foreign)
6:02am
6-K
qbw4 jmajw6u2h7
24 Jun 22
Current report (foreign)
6:08am
6-K
rk9iz
1 Jun 22
Current report (foreign)
6:08am
6-K
klo02
31 May 22
Current report (foreign)
6:20am
6-K
fqb1q1onmefk zt
31 May 22
Current report (foreign)
6:18am
6-K
EX-99.1
zybuhli tbe6h96cbfeu
31 May 22
Current report (foreign)
6:14am
6-K
EX-99.1
k9fapboi
31 May 22
Current report (foreign)
6:07am